Crossmark

Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

Crossref DOI link: https://doi.org/10.1016/j.arbres.2023.05.017

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carrasco Hernández, Laura

Girón Moreno, Rosa Mª

Balaguer Cartagena, Mari Nieves

Peláez, Adrián

Sole, Amparo

Álvarez Fernández, Antonio

Felipe Montiel, Almudena

Olveira, Casilda

Olveira, Gabriel

Gómez Bonilla, Ainhoa

Gómez Crespo, Beatriz

García Clemente, Marta

Solís García, Marta

Quaresma Vázquez, Joana

Blitz Castro, Enrique

Rodríguez González, Jesús

Expósito Marrero, Andrea

Diab-Cáceres, Laila

Ramos Hernández, Cristina

Zamarrón de Lucas, Ester

Prados Sanchez, Concha

Blanco Aparicio, Marina

López Neyra, Alejandro

Sanz Santiago, Verónica

Luna Paredes, Carmen

Delgado Pecellín, Isabel

Asensio de la Cruz, Óscar

Quintana Gallego, Esther
License Information

Text and Data Mining valid from 2023-09-01
More Information

This article is maintained by: Elsevier

Article Title: Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2023.05.017

Content Type: article

Copyright: © 2023 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.